Modern Medical's Opioid Defense Manager™
•Download as PPTX, PDF•
1 like•408 views
Looking for a solution to the workers' compensation opioid abuse? Check out Modern Medical's proactive program. Opioid Defense Manager™, protecting your employees, the physicians and you.
Report
Share
Report
Share
Recommended
media release mediscor mmr
Medicine expenditure in South Africa decreased slightly by 0.6% in 2012, continuing a downward trend from 2011. This is due to a 0.8% decrease in medicine utilization and a 0.2% increase in medicine item costs. The increased use of generic medicines, which have significantly lower costs, contributed to the decreased expenditure. Top therapeutic groups with the highest expenditure were treatments for hypertension, diabetes, and high cholesterol.
Pharmacy Global Track(s)
The document discusses three principles for European community pharmacy: monopoly on distributing medicine, ownership of pharmacies restricted to pharmacists, and geographical distribution of pharmacies. It then examines how the political, economic, and scientific landscape has changed since these principles were established. Finally, it argues that knowledge and the ability to apply knowledge will be key to addressing modern healthcare challenges in both developing and affluent countries.
Does patient engagement result in more appropriate utilization?
This presentation reviews what published research has established about how patient engagement improves the overall clinical experience and what that means for providers.
Why Prescriber Education is Important
What is the importance of continuing education for prescribers of extended-release, long-acting opioids?
Get the right cancer drug, at right Time
Mitra Biotech is a Boston and Bengaluru-based startup that is developing personalized cancer therapies. It focuses on testing drugs on recreated tumor microenvironments in the lab before human trials. This approach has higher success rates and lower toxicity than conventional trials. Mitra Biotech has raised over $27 million to develop these personalized therapies and diagnostics. Major challenges include high costs, ensuring data quality, and coordinating information between different treatment centers.
Sightseeing Pharmacy practice - The way forward
The document discusses future options for community pharmacy practice and trends influencing those options. It outlines four potential models for future pharmacy practice: a shop model focused on over-the-counter sales; a commercial chain model with limited professional services; a "MacPharmacy" model focused only on fast-moving prescriptions; and a professional practice/clinic model providing complex patient care services in collaboration with other health providers. Each model is described and questions are posed about how each option would impact patients, the profession, and monopoly over pharmacy services. Implementation of new practice models is discussed as requiring change management and addressing barriers through a stepwise project plan.
Journal Club Presentation Mb Rb
This document discusses the potential benefits and costs of implementing electronic medical record (EMR) systems in healthcare. It finds that EMR adoption could lead to significant efficiency savings of $77 billion per year at 90% adoption rates for both inpatient and outpatient care. EMRs are also estimated to reduce safety issues like adverse drug events, saving $1 billion for inpatients and $3.5 billion for outpatients. Widespread EMR use could further improve health outcomes for chronic disease prevention and management. However, barriers include the high costs of implementation for providers and the slow financial returns compared to upfront investment needs.
Reducing Health Costs
Money plays an important role in politics for several reasons. It takes a significant amount of time and money for candidates to reach all constituents given state population sizes. Data shows the best funded candidate won 91% of the time in 2012 Congressional races, spending on average over $1 million. The government is heavily involved in healthcare due to its large economic impact, the human impact of lack of access, and market failures in the healthcare system like asymmetric information and non-competitive markets. Lobbying and campaign contributions from the healthcare industry, which spends over $250 million annually on lobbying, also influence government policymaking in the area of healthcare.
Recommended
media release mediscor mmr
Medicine expenditure in South Africa decreased slightly by 0.6% in 2012, continuing a downward trend from 2011. This is due to a 0.8% decrease in medicine utilization and a 0.2% increase in medicine item costs. The increased use of generic medicines, which have significantly lower costs, contributed to the decreased expenditure. Top therapeutic groups with the highest expenditure were treatments for hypertension, diabetes, and high cholesterol.
Pharmacy Global Track(s)
The document discusses three principles for European community pharmacy: monopoly on distributing medicine, ownership of pharmacies restricted to pharmacists, and geographical distribution of pharmacies. It then examines how the political, economic, and scientific landscape has changed since these principles were established. Finally, it argues that knowledge and the ability to apply knowledge will be key to addressing modern healthcare challenges in both developing and affluent countries.
Does patient engagement result in more appropriate utilization?
This presentation reviews what published research has established about how patient engagement improves the overall clinical experience and what that means for providers.
Why Prescriber Education is Important
What is the importance of continuing education for prescribers of extended-release, long-acting opioids?
Get the right cancer drug, at right Time
Mitra Biotech is a Boston and Bengaluru-based startup that is developing personalized cancer therapies. It focuses on testing drugs on recreated tumor microenvironments in the lab before human trials. This approach has higher success rates and lower toxicity than conventional trials. Mitra Biotech has raised over $27 million to develop these personalized therapies and diagnostics. Major challenges include high costs, ensuring data quality, and coordinating information between different treatment centers.
Sightseeing Pharmacy practice - The way forward
The document discusses future options for community pharmacy practice and trends influencing those options. It outlines four potential models for future pharmacy practice: a shop model focused on over-the-counter sales; a commercial chain model with limited professional services; a "MacPharmacy" model focused only on fast-moving prescriptions; and a professional practice/clinic model providing complex patient care services in collaboration with other health providers. Each model is described and questions are posed about how each option would impact patients, the profession, and monopoly over pharmacy services. Implementation of new practice models is discussed as requiring change management and addressing barriers through a stepwise project plan.
Journal Club Presentation Mb Rb
This document discusses the potential benefits and costs of implementing electronic medical record (EMR) systems in healthcare. It finds that EMR adoption could lead to significant efficiency savings of $77 billion per year at 90% adoption rates for both inpatient and outpatient care. EMRs are also estimated to reduce safety issues like adverse drug events, saving $1 billion for inpatients and $3.5 billion for outpatients. Widespread EMR use could further improve health outcomes for chronic disease prevention and management. However, barriers include the high costs of implementation for providers and the slow financial returns compared to upfront investment needs.
Reducing Health Costs
Money plays an important role in politics for several reasons. It takes a significant amount of time and money for candidates to reach all constituents given state population sizes. Data shows the best funded candidate won 91% of the time in 2012 Congressional races, spending on average over $1 million. The government is heavily involved in healthcare due to its large economic impact, the human impact of lack of access, and market failures in the healthcare system like asymmetric information and non-competitive markets. Lobbying and campaign contributions from the healthcare industry, which spends over $250 million annually on lobbying, also influence government policymaking in the area of healthcare.
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...
Clinical results from application of paper-based medical error reduction/compliance program vs software-based MERP program implenented at 30 free-standing radiation oncology centers.
Cpoe Clinical Case
1) The document discusses strategies for increasing physician adoption of computerized physician order entry (CPOE) at hospitals, including establishing leadership support and messaging the clinical benefits to patients.
2) It recommends emphasizing how CPOE can reduce medication errors and improve adherence to evidence-based guidelines to improve patient care.
3) Studies show CPOE can reduce medication errors by an average of 66% and significantly reduce venous thromboembolism rates through improved guideline adherence for prevention.
Physician Practice in the Dynamic Health Care Environment Physician Practic...
This document discusses the many drivers that are changing the healthcare environment and physician practices. It outlines demographic changes like an aging population and increasing diversity. It also discusses changes in epidemiology as infectious diseases decline and chronic conditions rise. Rapid advances in technology, especially information technology and biotechnology, are also driving changes. Evolving consumer values and the stressed healthcare system have created disequilibrium. The roles of physicians and consumers are changing as movement toward integrated healthcare systems continues. Success for physician practices in the future will require understanding consumer needs, managing population health, deploying technology, and creating an adaptive practice culture.
Day 1 Speaker Presentation - Ayako Ebata
This document summarizes a presentation on access to health and antimicrobial resistance in developing countries. It discusses how weak health systems, pluralistic health systems, financial barriers to care, and lack of pharmaceutical regulations have contributed to the spread of antimicrobial resistance in Myanmar. A case study of Yangon region shows limited diagnostic capacity, symptom-based prescribing, few medical professionals, and over-the-counter antimicrobial access have driven resistance. Tackling antimicrobial resistance requires addressing its social, economic and political drivers through improved health systems, policies regulating pharmaceutical industries and livestock, and programs to promote rational antimicrobial use.
Inside the U.S. News Children’s Hospitals Rankings
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Pharma Final Presentation
This document discusses the history and current state of pharmaceutical marketing to physicians. It begins by describing how in the early 20th century, drug companies heavily advertised directly to consumers with exaggerated claims and few warnings. This led the AMA to encourage marketing directly to doctors instead and consider this "ethical". Today, common marketing tactics include drug representatives, sponsored medical education, gifts, and paying doctors for research. While companies claim this improves health outcomes, evidence shows it can influence prescription practices. Potential solutions proposed include prohibiting all gifts, banning sponsored education, and eliminating questionable payments to doctors.
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...Canadian Organization for Rare Disorders
This document provides a summary of a joint research report from the International Alliance of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on biologic medicines. It discusses how biologics have benefited over 350 million patients worldwide by treating illnesses like cancer, heart disease, and arthritis. The report aims to inform patients, health organizations, and policymakers on ensuring optimal, safe, and appropriate access to biologics globally. It explains what biologics are, how they should be regulated and monitored, and how patients can make informed decisions about their use. The document was authored by the Institute for Optimizing Health Outcomes, commissioned by IAPO andPharma Final Presentation
This document discusses the history and current state of pharmaceutical marketing to physicians. It begins by describing how in the early 20th century, drug companies heavily advertised directly to consumers with exaggerated claims and little oversight. This led the AMA to encourage marketing directly to doctors instead and establish drug standards. Today, major marketing tactics include drug reps, free samples, sponsoring conferences, and paying doctors. Regulations are largely voluntary, and gifts are allowed, though evidence suggests they influence prescribing habits. Potential solutions proposed include prohibiting all gifts, banning drug company education programs, and eliminating questionable payments to doctors.
A collaborative tale of quality and quantity enabling emergency physicians to...
A collaborative tale of quality and quantity enabling emergency physicians to...Canadian Patient Safety Institute
This study examined the impact of allowing emergency physicians to order CT scans without prior consultation with radiology at an urban academic hospital. The researchers found that enabling direct ordering did not increase CT utilization rates. Specifically:
1) Prior to the change, ordering CT scans required discussion between emergency physicians and radiology, leading to delays.
2) After implementing direct ordering between 8 AM to 5 PM on weekdays, the total number of CT scans ordered by emergency physicians decreased by 2.9% and the rate of CT scans per patient decreased by 1%.
3) The results suggest that streamlining the CT ordering process in this way can improve patient flow and length of stay without increasing radiation exposure from unnecessary scans.FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
Heroin
Heroin is an illegal and highly addictive drug derived from opium. It is typically taken by injection but can also be smoked or snorted. Use of heroin leads to a euphoric high but also serious health risks like overdose from the unpredictable potency of street drugs. The United States is experiencing a heroin epidemic, with a 50% rise in heroin use from 2002-2012 and over 680,000 people using heroin annually in 2013. Massachusetts alone saw over 200 heroin overdoses in a 3 month period of 2015. Treatment options for addiction include detox centers, counseling, therapy, and medication assistance programs.
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Daniel Blaney-Koen, American Medical Association, presented on The Nation's Opioid Epidemic: Are we Asking the Right Questions? at the State Legislative Conference on November 6, 2015.
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
Heroin treatment comparison
New Castle County police announced a new approach to fighting
the heroin epidemic with components of a similar strategy initiated
by police in Gloucester, Massachusetts.
Stop Selling Heroin
The document discusses the Stop Selling Heroin organization, which aims to combat heroin abuse and overdoses in Cape May County, New Jersey. It provides background on the heroin epidemic in the county, with over 50 deaths in 2012. The organization wants to approach drug dealers and users through their friends and family to encourage support groups and resources. It also includes a sample buyer persona, examples of social media use and advertising, and an initial media budget.
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...University of Michigan Injury Center
Presentation delivered at the University of Michigan Injury Center Opioid Overdose Summit, Ann Arbor, MI, December 1, 2015Opioids part1-2010
The document discusses the epidemiology and complications of illicit opioid use. It summarizes prevalence rates of heroin use in Australia, risk factors for developing problems, and associated medical and psychosocial risks like infections, overdose, mental health issues, and social consequences. Prescription opioid use and responsible prescribing are also briefly mentioned.
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
This document summarizes research on the intertwined opioid and heroin epidemics in the United States. It discusses trends showing rising overdose rates for both opioids and heroin since the 1990s. Qualitative interviews suggest many individuals transition from misusing prescription opioids to heroin. The epidemics are intertwined as the at-risk populations overlap and many initiate heroin use after developing dependency from prescription opioids. However, the heroin epidemic also involves a "heroin pull" from increased heroin availability and new forms of heroin being supplied. Ongoing challenges include addressing excessive opioid prescribing, improving surveillance of heroin products and use patterns, expanding treatment programs, and implementing harm reduction strategies.
Wed gs frieden
1) Prescription drug abuse in the U.S. has reached epidemic levels, with overdose deaths, opioid sales, and treatment admissions all rising in parallel since 1999. 2) To reverse the epidemic, efforts are needed to improve prescription drug monitoring programs (PDMPs), ensure safer opioid prescribing practices, expand access to treatment including buprenorphine, and support state-level prevention strategies. 3) Early evidence suggests that real-time, universal PDMPs; mandating their use; integrating them into electronic health records; and comprehensive laws can all help to reduce doctor shopping, opioid prescribing, and overdose deaths.
Steph Bonacorsi - Oxycontin Epidemc
The document discusses the opioid epidemic in the United States, focusing on the role of OxyContin. It describes how OxyContin became widely prescribed due to a shift in pain treatment philosophy in the 1980s, an aggressive marketing campaign by Purdue Pharma claiming the drug had a low addiction risk, and changes in physician prescribing habits. However, OxyContin proved to be highly addictive, and increased opioid prescriptions correlated with rising overdose rates. Purdue Pharma was later found to have misleadingly marketed OxyContin and paid fines, but the epidemic had already taken hold across the nation. The FDA and state governments have since implemented measures to curb inappropriate opioid prescribing and monitor distribution.
The Prescription Drug Epidemic:
This document summarizes a presentation given by Dr. Michael M. Miller on the prescription drug epidemic in the United States. It discusses how increased recognition of pain and addiction as medical conditions has led to more opioid prescriptions being written, resulting in higher rates of addiction, overdoses and deaths. While aiming to improve care, policies promoting greater opioid prescribing have had unintended consequences. The shortage of specialists means general physicians often lack training to safely evaluate and treat pain or addiction. Rising opioid prescription drug abuse now poses a major public health crisis in the U.S.
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...University of Michigan Injury Center
Presentation delivered at the University of Michigan Injury Center Opioid Overdose Summit, Ann Arbor, MI, December 1, 2015More Related Content
What's hot
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...
Clinical results from application of paper-based medical error reduction/compliance program vs software-based MERP program implenented at 30 free-standing radiation oncology centers.
Cpoe Clinical Case
1) The document discusses strategies for increasing physician adoption of computerized physician order entry (CPOE) at hospitals, including establishing leadership support and messaging the clinical benefits to patients.
2) It recommends emphasizing how CPOE can reduce medication errors and improve adherence to evidence-based guidelines to improve patient care.
3) Studies show CPOE can reduce medication errors by an average of 66% and significantly reduce venous thromboembolism rates through improved guideline adherence for prevention.
Physician Practice in the Dynamic Health Care Environment Physician Practic...
This document discusses the many drivers that are changing the healthcare environment and physician practices. It outlines demographic changes like an aging population and increasing diversity. It also discusses changes in epidemiology as infectious diseases decline and chronic conditions rise. Rapid advances in technology, especially information technology and biotechnology, are also driving changes. Evolving consumer values and the stressed healthcare system have created disequilibrium. The roles of physicians and consumers are changing as movement toward integrated healthcare systems continues. Success for physician practices in the future will require understanding consumer needs, managing population health, deploying technology, and creating an adaptive practice culture.
Day 1 Speaker Presentation - Ayako Ebata
This document summarizes a presentation on access to health and antimicrobial resistance in developing countries. It discusses how weak health systems, pluralistic health systems, financial barriers to care, and lack of pharmaceutical regulations have contributed to the spread of antimicrobial resistance in Myanmar. A case study of Yangon region shows limited diagnostic capacity, symptom-based prescribing, few medical professionals, and over-the-counter antimicrobial access have driven resistance. Tackling antimicrobial resistance requires addressing its social, economic and political drivers through improved health systems, policies regulating pharmaceutical industries and livestock, and programs to promote rational antimicrobial use.
Inside the U.S. News Children’s Hospitals Rankings
Speaker Presentation from U.S. News Healthcare of Tomorrow leadership summit, November 2-4, 2016 in Washington, DC. Find out more about this forum at www.usnewshot.com.
Pharma Final Presentation
This document discusses the history and current state of pharmaceutical marketing to physicians. It begins by describing how in the early 20th century, drug companies heavily advertised directly to consumers with exaggerated claims and few warnings. This led the AMA to encourage marketing directly to doctors instead and consider this "ethical". Today, common marketing tactics include drug representatives, sponsored medical education, gifts, and paying doctors for research. While companies claim this improves health outcomes, evidence shows it can influence prescription practices. Potential solutions proposed include prohibiting all gifts, banning sponsored education, and eliminating questionable payments to doctors.
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...Canadian Organization for Rare Disorders
This document provides a summary of a joint research report from the International Alliance of Patients’ Organisations (IAPO) and the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on biologic medicines. It discusses how biologics have benefited over 350 million patients worldwide by treating illnesses like cancer, heart disease, and arthritis. The report aims to inform patients, health organizations, and policymakers on ensuring optimal, safe, and appropriate access to biologics globally. It explains what biologics are, how they should be regulated and monitored, and how patients can make informed decisions about their use. The document was authored by the Institute for Optimizing Health Outcomes, commissioned by IAPO andPharma Final Presentation
This document discusses the history and current state of pharmaceutical marketing to physicians. It begins by describing how in the early 20th century, drug companies heavily advertised directly to consumers with exaggerated claims and little oversight. This led the AMA to encourage marketing directly to doctors instead and establish drug standards. Today, major marketing tactics include drug reps, free samples, sponsoring conferences, and paying doctors. Regulations are largely voluntary, and gifts are allowed, though evidence suggests they influence prescribing habits. Potential solutions proposed include prohibiting all gifts, banning drug company education programs, and eliminating questionable payments to doctors.
A collaborative tale of quality and quantity enabling emergency physicians to...
A collaborative tale of quality and quantity enabling emergency physicians to...Canadian Patient Safety Institute
This study examined the impact of allowing emergency physicians to order CT scans without prior consultation with radiology at an urban academic hospital. The researchers found that enabling direct ordering did not increase CT utilization rates. Specifically:
1) Prior to the change, ordering CT scans required discussion between emergency physicians and radiology, leading to delays.
2) After implementing direct ordering between 8 AM to 5 PM on weekdays, the total number of CT scans ordered by emergency physicians decreased by 2.9% and the rate of CT scans per patient decreased by 1%.
3) The results suggest that streamlining the CT ordering process in this way can improve patient flow and length of stay without increasing radiation exposure from unnecessary scans.What's hot (9)
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...
SROA Presentation - Clinical Results of a Medical Error Reduction/Compliance ...
Physician Practice in the Dynamic Health Care Environment Physician Practic...
Physician Practice in the Dynamic Health Care Environment Physician Practic...
Inside the U.S. News Children’s Hospitals Rankings
Inside the U.S. News Children’s Hospitals Rankings
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
Afternoon Session A Consultation on Patented Medicine Prices Review Board & B...
A collaborative tale of quality and quantity enabling emergency physicians to...
A collaborative tale of quality and quantity enabling emergency physicians to...
Viewers also liked
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
The document summarizes the opioid epidemic in the United States and the response from the Department of Health and Human Services (HHS). It provides data showing that prescription opioids are the most commonly abused drugs and that opioid overdose deaths have increased significantly since 1999. The HHS Secretary launched an Opioid Initiative in 2015 focused on improving opioid prescribing practices, increasing access to naloxone to reverse overdoses, and expanding medication-assisted treatment for opioid use disorders. Partnerships with health organizations aim to train providers and increase access to prevention and treatment services. States like Washington that implemented comprehensive approaches have seen declines in overdose deaths and hospitalizations.
Heroin
Heroin is an illegal and highly addictive drug derived from opium. It is typically taken by injection but can also be smoked or snorted. Use of heroin leads to a euphoric high but also serious health risks like overdose from the unpredictable potency of street drugs. The United States is experiencing a heroin epidemic, with a 50% rise in heroin use from 2002-2012 and over 680,000 people using heroin annually in 2013. Massachusetts alone saw over 200 heroin overdoses in a 3 month period of 2015. Treatment options for addiction include detox centers, counseling, therapy, and medication assistance programs.
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Daniel Blaney-Koen, American Medical Association, presented on The Nation's Opioid Epidemic: Are we Asking the Right Questions? at the State Legislative Conference on November 6, 2015.
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
The document discusses efforts to address the opioid epidemic in the United States, including:
- Increasing registration and use of prescription drug monitoring programs (PDMPs) to track opioid prescriptions.
- Reducing the stigma around both pain and substance use disorder to increase access to comprehensive treatment.
- Expanding access to naloxone to prevent overdose deaths and "Good Samaritan" legal protections.
- Ongoing education of physicians on safe opioid prescribing and alternative pain management strategies.
Heroin treatment comparison
New Castle County police announced a new approach to fighting
the heroin epidemic with components of a similar strategy initiated
by police in Gloucester, Massachusetts.
Stop Selling Heroin
The document discusses the Stop Selling Heroin organization, which aims to combat heroin abuse and overdoses in Cape May County, New Jersey. It provides background on the heroin epidemic in the county, with over 50 deaths in 2012. The organization wants to approach drug dealers and users through their friends and family to encourage support groups and resources. It also includes a sample buyer persona, examples of social media use and advertising, and an initial media budget.
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...University of Michigan Injury Center
Presentation delivered at the University of Michigan Injury Center Opioid Overdose Summit, Ann Arbor, MI, December 1, 2015Opioids part1-2010
The document discusses the epidemiology and complications of illicit opioid use. It summarizes prevalence rates of heroin use in Australia, risk factors for developing problems, and associated medical and psychosocial risks like infections, overdose, mental health issues, and social consequences. Prescription opioid use and responsible prescribing are also briefly mentioned.
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
This document summarizes research on the intertwined opioid and heroin epidemics in the United States. It discusses trends showing rising overdose rates for both opioids and heroin since the 1990s. Qualitative interviews suggest many individuals transition from misusing prescription opioids to heroin. The epidemics are intertwined as the at-risk populations overlap and many initiate heroin use after developing dependency from prescription opioids. However, the heroin epidemic also involves a "heroin pull" from increased heroin availability and new forms of heroin being supplied. Ongoing challenges include addressing excessive opioid prescribing, improving surveillance of heroin products and use patterns, expanding treatment programs, and implementing harm reduction strategies.
Wed gs frieden
1) Prescription drug abuse in the U.S. has reached epidemic levels, with overdose deaths, opioid sales, and treatment admissions all rising in parallel since 1999. 2) To reverse the epidemic, efforts are needed to improve prescription drug monitoring programs (PDMPs), ensure safer opioid prescribing practices, expand access to treatment including buprenorphine, and support state-level prevention strategies. 3) Early evidence suggests that real-time, universal PDMPs; mandating their use; integrating them into electronic health records; and comprehensive laws can all help to reduce doctor shopping, opioid prescribing, and overdose deaths.
Steph Bonacorsi - Oxycontin Epidemc
The document discusses the opioid epidemic in the United States, focusing on the role of OxyContin. It describes how OxyContin became widely prescribed due to a shift in pain treatment philosophy in the 1980s, an aggressive marketing campaign by Purdue Pharma claiming the drug had a low addiction risk, and changes in physician prescribing habits. However, OxyContin proved to be highly addictive, and increased opioid prescriptions correlated with rising overdose rates. Purdue Pharma was later found to have misleadingly marketed OxyContin and paid fines, but the epidemic had already taken hold across the nation. The FDA and state governments have since implemented measures to curb inappropriate opioid prescribing and monitor distribution.
The Prescription Drug Epidemic:
This document summarizes a presentation given by Dr. Michael M. Miller on the prescription drug epidemic in the United States. It discusses how increased recognition of pain and addiction as medical conditions has led to more opioid prescriptions being written, resulting in higher rates of addiction, overdoses and deaths. While aiming to improve care, policies promoting greater opioid prescribing have had unintended consequences. The shortage of specialists means general physicians often lack training to safely evaluate and treat pain or addiction. Rising opioid prescription drug abuse now poses a major public health crisis in the U.S.
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...University of Michigan Injury Center
Presentation delivered at the University of Michigan Injury Center Opioid Overdose Summit, Ann Arbor, MI, December 1, 2015Tue gs mc cance-katz
This document discusses the importance of treatment for opioid use disorders. It notes the rise in prescription pain medication abuse and related harms like overdoses. Treatment options like medication-assisted treatment with drugs like methadone and buprenorphine combined with counseling can effectively treat opioid addiction, improving health and social outcomes. The Substance Abuse and Mental Health Services Administration promotes such evidence-based treatment approaches and prevention efforts to address the prescription drug abuse epidemic.
Cl 4 salsitz
Clinical: ER/LA Opioid REMS - Achieving Safe Use While Improving Patient Care, Part 1 - Dr. Stuart Gitlow and Dr. Edwin Salsitz
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
The director of the CDC discussed the prescription drug and opioid overdose epidemic in the United States. He noted that over 145,000 lives have been lost to prescription opioid overdoses in the past decade as opioid prescribing has increased 4-fold since 1999. The CDC is working with multiple states experiencing outbreaks of HIV linked to injection drug use. The director outlined a potential "technical package" of interventions including improving prescribing practices, increasing access to treatment, reducing drug availability, and public awareness campaigns. Progress requires a comprehensive, evidence-based public health approach with law enforcement and community involvement.
Rx16 pharma tues_200_1_kelly_2ream_3shanehsaz
This document summarizes a presentation on technologies to reduce prescription drug diversion, fraud, and abuse through electronic prescribing and drug deactivation systems. It discusses Delaware's pilot program with an at-home drug deactivation system. The presentation describes how electronic prescribing of controlled substances can reduce diversion and fraud while improving patient satisfaction. It also outlines DEA requirements for electronic prescribing and discusses Cambridge Health Alliance's experience implementing electronic prescribing of controlled substances with Epic and Imprivata. Finally, it summarizes the results of Delaware's pilot program, which provided at-home drug deactivation systems to specific pharmacies to promote safe disposal of unused prescription drugs.
Rx15 workshop mon_200_aleshire_dowell_no_notes
Pre-Summit Workshop: A Centers for Disease Control and Prevention (CDC) Primer on the Rx Drug Overdose Epidemic
Rx16 heroin tues_1115_1_walls_2kolodny
The origins of the current heroin crisis in America can be traced back to the overprescription of opioid painkillers in recent decades. As opioid prescriptions and sales increased aggressively starting in the late 1990s, so too did rates of opioid addiction, overdose deaths, and users transitioning from prescription opioids to heroin. While heroin use has been an issue in the past as well, linked to wars and social movements, the current crisis is uniquely tied to changes in opioid prescribing practices that flooded the country with highly addictive pain pills and helped reintroduce heroin as a cheaper alternative to prescription opioids.
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
This presentation, to an international web audience, was presented alongside one by Dr Wilson Compton, Deputy Director of the National Institute on Drug Abuse. Sponsored by NDEWS, it explores the structural reasons for the emerging heroin overdose epidemic and ways to address it.
Viewers also liked (20)
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
FMCC 2016 Curbing Rx Drug Abuse Plenary by Christopher Jones
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
Prescription Drug Abuse, Daniel Blaney-Koen - SLC 2015
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
FMCC 2016 Curbing Rx Drug Abuse Plenary by Daniel Blaney-Koen
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
Prescription Drug Poisoning: No Longer a Silent Epidemic by Christy Porucznik...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
National Academies of Science and Medicine: Intertwined Epidemics: Opioid and...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
CDC Initiatives & Priorities to Address the Prescription Drug Overdose Crisis...
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
Wed frieden web-version_rx_od (unite) - apr 8 -video_external
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
National Drug Early Warning (NDEWS) webinar: A more dangerous heroin: Emergin...
Similar to Modern Medical's Opioid Defense Manager™
Opioid Epidemic - Causes, Impact and Future
In 2017, everyday, more than 130 people died in the US after overdosing on opioids. This document talks about America's worst drug crisis ever and shares how technology can play a role to cope up with this epidemic.
The Opioid Epidemic - N Elkins
This presentation discusses the opioid epidemic, guidelines for prescribing opioids, and strategies for managing postoperative pain with reduced opioid use. It provides objectives about understanding the societal costs of the opioid epidemic, complying with state prescribing laws, and following guidelines for different types of pain. The presentation reviews CDC guidelines for prescribing opioids, the Arizona prescription drug monitoring program, factors influencing opioid use, and results from a study showing most patients use fewer opioids than prescribed after surgery. It emphasizes multimodal analgesia, patient education, and tapering or discontinuing certain medications before surgery to reduce postoperative opioid needs.
Health System Response to Opioid Overdose (Diversion) by Jeffrey S. Desmond, MD
Health System Response to Opioid Overdose (Diversion) by Jeffrey S. Desmond, MDUniversity of Michigan Injury Center
Jeffrey Desmond, interim chief medical officer at the University of Michigan Health System, gave a presentation at an opioid overdose summit on December 1, 2015. He called on physicians to carefully assess addiction risk before prescribing opioids and to prescribe the smallest dose for shortest time possible. He also encouraged open discussions between doctors and patients about opioid risks and alternatives. The presentation discussed issues with controlled substance diversion at UMHS, including a nurse's death and doctor's overdose, and 16,000 missing pills. It outlined comprehensive programs implemented to improve accountability, security, and monitoring of controlled substances. The summit aimed to bring attention to the growing issue of prescription opioid abuse and facilitate research collaborations.Safe & Effective Management of Chronic Pain
PEG (Pain, Enjoyment, General activity) scale (0-10)
1. What number best describes your Pain on average in the past week? 5 → 5 (no change)
2. What number best describes how much you are Enjoying life?
3 → 7 (worsening)
3. What number best describes your General activity level?
4 → 9 (worsening)
Safe & Effective Management of Chronic Pain
I do not have access to the video cases you referenced. Could you please provide a brief summary of the key details in each case so I can try to understand and respond to your questions? Without more context it's difficult for me to analyze how the provider handled the situation or determine the diagnosis.
Cost saving strategies_updated
Third-Party Payer Track, National Rx Drug Abuse Summit, April 2-4, 2013. Presentation by Dr. Steven Moskowitz and Dr. Jeremy Corbett.
Pharmacy drug adherence march2013
Pharmacy drug adherence is important for both healthcare providers and patients. Value-based treatment involves choosing a drug regimen that controls disease progression while improving quality of life through medication compliance. However, low patient adherence costs the pharmaceutical industry over $500 billion per year, driving up drug prices and competition from generics. A proposed analytics solution segments patient populations by adherence behavior, profiles disease progression retrospectively in each segment, and uses predictive analytics to alert pharmacists about non-compliance risks so they can better communicate with patients about negative health outcomes from low adherence. This could help modify patient behavior, save $290 billion annually, and help meet goals of the Affordable Care Act by making patients more active participants in their own care.
medication error.pptx
This document provides an overview of medication safety and medication errors. It defines key terms like medical error, adverse drug events, and near misses. It discusses the scale of medication errors, estimating they occur in 5-14% of doses dispensed and 1 in 100 result in an adverse drug event. Preventable medical errors occur in over 3 million hospital admissions and outpatient visits annually in the US, resulting in over 7,000 deaths each year. Factors that contribute to medication errors include complex medication regimens and lack of communication between healthcare providers. Strategies to improve safety include using generic drug names, tailoring prescriptions to each patient, thorough medication histories, awareness of high-risk medications, and encouraging patient involvement.
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
This document discusses strategies to curb prescription drug abuse, specifically opioid abuse, in West Virginia. It notes that West Virginia has the highest drug overdose mortality rate in the US and clinicians there write a high number of opioid prescriptions. It explores reasons for high prescribing rates and discusses solutions like improving education for patients and doctors, changing financial incentives, using prescription drug monitoring programs, and following CDC guidelines for safer opioid prescribing. Alternative therapies for pain management and the role of EDIE in monitoring patients and interfacing with PDMPs are also covered. The document advocates for internal referrals to pain specialists and multidisciplinary approaches to pain care.
Rx15 tpp wed_300_1_paduda-white_2hanna
This document summarizes a presentation on workers' compensation policy issues and solutions related to opioids. It includes discussions from three presenters on topics like the Ohio Bureau of Workers' Compensation pharmacy program, physician dispensing of opioids, and policy reforms. The Ohio BWC program presentation describes the program's formulary changes from 2011-2014 to curb opioid utilization and other drug spending. It also evaluates the program's impact on reducing opioid prescriptions and medical costs. The physician dispensing presentation examines the financial incentives for dispensing and higher claim costs when physicians dispense opioids. It advocates for legislative reforms to curb dispensing to improve outcomes.
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
This document summarizes a survey of Medicaid Schedule II opioid prescriptions from May 1st to July 31st, 2015. It found that hydrocodone claims made up 80.1% of all claims and patients received on average 2 prescriptions totaling 2527.2 mg of morphine equivalent. The analysis identified 3641 patients, 1734 prescribers, and 1956 pharmacies with high opioid usage. These "flagged" entities accounted for 19,376 claims totaling a high dosage. The document recommends further investigating these targets and integrating with other programs to address the opioid epidemic.
final duplication and misuse ppt
Duplication prescribing and misuse of medicine can harm patients and lead to death. Duplication prescribing occurs when multiple medications are prescribed for the same condition without coordination. Misuse involves using medication other than as intended, such as through addiction. Strategies to reduce these risks include implementing electronic health records and clinical decision support to avoid therapeutic duplication, educating patients, and enhancing prescription drug monitoring programs and enforcement of drug disposal laws.
Rx Medal Presentation
This document describes a pharmacy program called Rx MEDAL that aims to improve patient outcomes and reduce healthcare costs through medication adherence and condition monitoring for chronic diseases. The program uses adherence monitoring, motivational interviewing, and condition scoring to help patients better manage conditions like diabetes, hypertension, heart failure and COPD. Research shows that higher medication adherence scores through this type of program can significantly reduce healthcare costs and hospitalization risks for patients with chronic conditions.
Challenges in Managing Cancer Pain: The Role of the Oncology Pharmacist
The correct answer is E. All of the strategies listed can be used by oncology or supportive care pharmacists to better manage pain in patients in the hospital setting.
International Patient Safety Goals (IPSG)
International Patient Safety Goals (IPSG) were developed in 2006 by Joint Commission International (JCI). It helps accredited organizations address specific areas of concern in some of the most problematic areas of patient safety.
Cms opioid-misuse-strategy-2016
The Centers for Medicare & Medicaid Services outlines their opioid misuse strategy to address the national opioid epidemic. Their strategy includes 4 priority areas: 1) implementing more effective strategies to reduce risks of opioid use disorder, overdoses, and inappropriate prescribing; 2) expanding access to naloxone to reverse overdoses; 3) expanding screening, diagnosis, and treatment of opioid use disorder including medication-assisted treatment; and 4) increasing use of evidence-based practices for pain management. Opioid misuse has led to alarming increases in overdoses and deaths, and CMS aims to combat this through promoting safe opioid use, improving access to treatment, and alternative pain management options.
Mhealth for improved medication adherence
This document discusses medication adherence and proposes a mHealth approach using automated medication reminders triggered from pharmacy dispensing data to improve adherence. Key points:
- Medication non-adherence is a major healthcare problem, with 50% of chronic patients not following treatment plans. This costs $100-290 billion annually in the US.
- An automated reminder system would use dispensing data like medication name, dose, frequency from pharmacies to set reminders in an app to prompt users when to take medications and track adherence.
- This approach could improve medication adherence rates especially as more use smartphones and wearables, helping address the large costs and health impacts of non-adherence.
Tx 1 dupont
Treatment: The Role of Medication-Assisted Treatment (MAT) in the Nonmedical Opioid Epidemic - Dr. Robert DuPont
Pharmaceutical care
Based on the information provided:
- Mrs. Tigist's drug-related need is for effective treatment of her depression
- Recommending an OTC sleep aid would not meet this need and could potentially cause harm
- The appropriate action would be to advise Mrs. Tigist that her symptoms suggest she may be depressed and recommend she see her physician for evaluation and treatment
Rational drug therapy
This document discusses rational drug therapy and the essential drug concept. It defines essential medicines as drugs that provide the best balance of quality, safety, efficacy and cost for treating most of the population. The objectives of rational drug therapy are to maximize effectiveness and safety, identify patients needing counseling, minimize medication errors, and provide balance among factors for rational drug use and healthcare costs. The principles of essential drug concept are maximum treatment with minimum drugs, adequate drug utilization, and economic and efficient activities with proper patient information. The pharmacist plays an important role in counseling, reporting adverse drug reactions, drug procurement, inventory control, and promoting rational drug usage.
Similar to Modern Medical's Opioid Defense Manager™ (20)
Health System Response to Opioid Overdose (Diversion) by Jeffrey S. Desmond, MD
Health System Response to Opioid Overdose (Diversion) by Jeffrey S. Desmond, MD
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
FMCC 2016 Curbing Rx Drug Abuse Plenary by Sarah Chouinard
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
Shannon_Zhang_Project_Presentation_Disclaimer_Credits
Challenges in Managing Cancer Pain: The Role of the Oncology Pharmacist
Challenges in Managing Cancer Pain: The Role of the Oncology Pharmacist
Recently uploaded
All info about Diabetes and how to control it.
One health condition that is becoming more common day by day is diabetes.
According to research conducted by the National Family Health Survey of India, diabetic cases show a projection which might increase to 10.4% by 2030.
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
This document outlines policies and procedures for handling narcotic and controlled drugs in NABH accredited hospitals.
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Ketone bodies and metabolism-biochemistry
This slide consists of all the topics of ketone . This can be used for exam purpose for writing about Diabetic keto acidosis etc . Thank you
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Role of Mukta Pishti in the Management of Hyperthyroidism
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Adhd Medication Shortage Uk - trinexpharmacy.com
The UK is currently facing a Adhd Medication Shortage Uk, which has left many patients and their families grappling with uncertainty and frustration. ADHD, or Attention Deficit Hyperactivity Disorder, is a chronic condition that requires consistent medication to manage effectively. This shortage has highlighted the critical role these medications play in the daily lives of those affected by ADHD. Contact : +1 (747) 209 – 3649 E-mail : sales@trinexpharmacy.com
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS). Parc Taulí. Sabadell
The Electrocardiogram - Physiologic Principles
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
Efficacy of Avartana Sneha in Ayurveda
Avartana Sneha is a unique method of Preparation of Sneha Kalpana in Ayurveda, mainly it is indicated for the Vataja rogas.
share - Lions, tigers, AI and health misinformation, oh my!.pptx
• Pitfalls and pivots needed to use AI effectively in public health
• Evidence-based strategies to address health misinformation effectively
• Building trust with communities online and offline
• Equipping health professionals to address questions, concerns and health misinformation
• Assessing risk and mitigating harm from adverse health narratives in communities, health workforce and health system
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
A proprietary approach developed by bringing together the best of learning theories from Psychology, design principles from the world of visualization, and pedagogical methods from over a decade of training experience, that enables you to: Learn better, faster!
Journal Article Review on Rasamanikya
Rasamanikya is a excellent preparation in the field of Rasashastra, it is used in various Kushtha Roga, Shwasa, Vicharchika, Bhagandara, Vatarakta, and Phiranga Roga. In this article Preparation& Comparative analytical profile for both Formulationon i.e Rasamanikya prepared by Kushmanda swarasa & Churnodhaka Shodita Haratala. The study aims to provide insights into the comparative efficacy and analytical aspects of these formulations for enhanced therapeutic outcomes.
Hiranandani Hospital Powai News [Read Now].pdf
Hiranandani Hospital in Powai, Mumbai, is a premier healthcare institution that has been serving the community with exceptional medical care since its establishment. As a part of the renowned Hiranandani Group, the hospital is committed to delivering world-class healthcare services across a wide range of specialties, including kidney transplantation. With its state-of-the-art facilities, advanced medical technology, and a team of highly skilled healthcare professionals, Hiranandani Hospital has earned a reputation as a trusted name in the healthcare industry. The hospital's patient-centric approach, coupled with its focus on innovation and excellence, ensures that patients receive the highest standard of care in a compassionate and supportive environment.
Recently uploaded (20)
Osteoporosis - Definition , Evaluation and Management .pdf
Osteoporosis - Definition , Evaluation and Management .pdf
Histopathology of Rheumatoid Arthritis: Visual treat
Histopathology of Rheumatoid Arthritis: Visual treat
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
Integrating Ayurveda into Parkinson’s Management: A Holistic Approach
share - Lions, tigers, AI and health misinformation, oh my!.pptx
share - Lions, tigers, AI and health misinformation, oh my!.pptx
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Modern Medical's Opioid Defense Manager™
- 1. TM
- 2. Why We Need to Better Manage Opioids “ In all likelihood, hundreds of claimants are dying every year as a direct result of opioid abuse.” - Joe Paduda, Work Comp Central “The rate of chronic non-medical use of prescription opioids has increased by 74.6% since 2003.” - CM Jones, Arch Intern Med “Prescription drug abuse results in one death every 19 minutes in the United States.” - drugfree.org
- 3. Opioid Abuse = Epidemic The Center for Disease Control calls opioid abuse an “epidemic”. The cost of this epidemic: • Thousands of lost work hours • Millions of dollars on medical expenses • Loss of life
- 4. Modern Medical’s Solution TM Revolutionary manage care program Helps reduce inappropriate drug use Protect claimants by monitoring prescriptions and use
- 5. The key benefit lies in our mission to protect the injured employee.
- 6. Claimant Centered Approach • ODM™ is designed to be claimant centered, focusing on prevention. • The pharmacist, nurse and prescriber work together to ensure appropriate use of opioid and monitors potential abuse.
- 7. Nurse Intervention • Proactively monitor claimant’s use of opioids • Review physician reports • Track progress reports, pain agreements and outcomes • Customizable • Same alerts and reports whether using Modern Medical’s nurse or your own nurse
- 8. Technology Driving ODM™ Claims management web portal where adjusters can review ODM™ claimants, set alerts and take actions. Used by Modern Medical’s staff to track outcomes for pain, function, opioid use, adverse effects, urine drug screens and pain agreements. Prescriber intervention program working with ODM™ alerts to identify and address issues with opioid and other inappropriate drug use.
- 9. For additional information on Opioid Defense Manager™, contact Modern Medical at: (800) 547-3330 modernmedical.com